CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
Ziranu P, Pretta A, Pozzari M, Maccioni A, Badiali M, Fanni D, Lai E, Donisi C, Persano M, Gerosa C, Puzzoni M, Bardanzellu F, Ambu R, Pusceddu V, Dubois M, Cerrone G, Migliari M, Murgia S, Spanu D, Pretta G, Aimola V, Balconi F, Murru S, Faa G, Scartozzi M.
Ziranu P, et al. Among authors: ambu r.
Sci Rep. 2023 Mar 16;13(1):4397. doi: 10.1038/s41598-023-31538-3.
Sci Rep. 2023.
PMID: 36928082
Free PMC article.